![Robin Hallett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robin Hallett
Nessuna posizione attualmente
Profilo
Robin Hallett worked as the Head of Translational Sciences at Northern Biologics, Inc. and as the Vice President of Discovery & Translational Sciences at POINT Biopharma Global, Inc. She holds a doctorate degree from McMaster University.
Precedenti posizioni note di Robin Hallett
Società | Posizione | Fine |
---|---|---|
POIT BIOP | Corporate Officer/Principal | 27/12/2023 |
Northern Biologics, Inc.
![]() Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Formazione di Robin Hallett
McMaster University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
POIT BIOP | Health Technology |
Aziende private | 1 |
---|---|
Northern Biologics, Inc.
![]() Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Health Services |
- Borsa valori
- Insiders
- Robin Hallett